Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H21NO3 |
| Molecular Weight | 275.3428 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](O)C(=O)NCC[C@@H]1CCC2=CC=C3OCCC3=C12
InChI
InChIKey=FGFNIJYHXMJYJN-JQWIXIFHSA-N
InChI=1S/C16H21NO3/c1-10(18)16(19)17-8-6-12-3-2-11-4-5-14-13(15(11)12)7-9-20-14/h4-5,10,12,18H,2-3,6-9H2,1H3,(H,17,19)/t10-,12-/m0/s1
| Molecular Formula | C16H21NO3 |
| Molecular Weight | 275.3428 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:36:08 UTC 2023
by
admin
on
Sat Dec 16 17:36:08 UTC 2023
|
| Record UNII |
P4VWQ9NHF2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P4VWQ9NHF2
Created by
admin on Sat Dec 16 17:36:09 UTC 2023 , Edited by admin on Sat Dec 16 17:36:09 UTC 2023
|
PRIMARY | |||
|
68501275
Created by
admin on Sat Dec 16 17:36:09 UTC 2023 , Edited by admin on Sat Dec 16 17:36:09 UTC 2023
|
PRIMARY | |||
|
1639809-89-4
Created by
admin on Sat Dec 16 17:36:09 UTC 2023 , Edited by admin on Sat Dec 16 17:36:09 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
AGONIST
Ki
|
||
|
|
TARGET -> AGONIST |
AGONIST
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
metabolite M-II, has a longer half-life and greater systemic exposure than ramelteon. Hence, M-II may contribute significantly to the hypnotic benefits of ramelteon. S-ISOMER represents 94% of M-II.
|
